Powered by Google

2015-07: Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration

Medical retina
Drug research
Contract Research
Inclusion open since 15-4-2016

The purpose of this study is to assess safety and efficacy of abicipar compared with ranibizumab in treatment-naïve patients with neovascular age-related macular degeneration.

By visiting eyehospital.nl you are accepting the use of cookies. Read more about cookies.

Hide this message